Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. - Wikidata - awgldk - TriplyDB

Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.

Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.

http://www.wikidata.org/entity/Q33360668

about

Behçet's Uveitis.Risk of relapse in primary acute anterior uveitis.Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis.The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics.Success with single-agent immunosuppression for multifocal choroidopathies.Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema Ischemic retinal vasculitis and its management.Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.Clinical trials in noninfectious uveitis Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients Correlation between Fluorescein Angiographic Findings and Visual Acuity in Behçet Retinal Vasculitis.Morbus Behçet - a rare disease in Central Europe.Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial The Effectiveness of Intraocular Methotrexate in the Treatment of Posterior Uveitis in Behçet's Disease Patients Compared to Retrobulbar Steroids Injection.Severe panuveitis in neuro-Behçet's disease in Malaysia: a case series.Evaluation of current therapeutic strategies in Behçet's disease.Controversies in Behçet disease.Light on the horizont: biologicals in Behçet uveitis.Epidemiology of Behçet disease.Differential diagnosis of behçet uveitis.Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.Ocular Behçet's Disease: Changing Patterns Over Time, Complications and Long-Term Visual Prognosis.The Effectiveness of Pre- and Postoperative Infliximab in Controlling Behçet's Disease Posterior Uveitis in Patients Undergoing Vitrectomy: A Preliminary Study.Behçet's disease leaves the silk road.Enhanced depth imaging optical coherence tomography findings in Behçet disease.Immunosuppression for the Uveitides.Clinical Characteristics and Prognostic Factors in Ankylosing Spondylitis Associated Uveitis.Long-Term Efficacy and Safety of Interferon Alpha-2a in the Treatment of Chinese Patients with Behçet's Uveitis Not Responding to Conventional Therapy.Changes in Ocular Manifestations of Behçet Disease in Korean Patients over Time: A Single-center Experience in the 1990s and 2000s

P2860

Q33559788-7F906329-4C9F-4127-A328-EDE925C988C8 Q33934732-BFB7AD1C-31B1-4EB3-8A96-1167CBD108BB Q34154889-70332DDF-F919-4480-8BF9-42B590251529 Q34286402-D4D3E93B-9B37-4E95-BC0F-2A8D1805B1BB Q34623981-3595D85D-99B2-48C9-A3ED-15A26AF2337E Q35065882-7F3528F4-D616-4C9A-A507-75F0E4E7F001 Q35170689-830ECDAA-2202-474F-9908-039A0731E88C Q35319079-7BF555F8-43AB-444D-8F3C-66931CC42420 Q35681664-4191C1BD-917D-4BC9-9D78-DA1BAD99290C Q35699360-07A8F0AF-A5B0-4032-B601-0964FFB1057D Q35778203-B08F7F9C-935D-4A10-B1D4-5AF05331AE47 Q36418989-4864E335-535C-435D-ADB1-BFAAC65DCE09 Q36722509-EEBB1C78-3892-4D64-80E0-2DA092749334 Q37533495-1B6F7721-27E6-4F65-9DC4-92A9C59F385E Q37638766-2B9F1636-6544-4AB1-9C9A-903A4411073C Q37788987-3BBB318C-8940-45D8-A2BA-0735008D9E4A Q37983120-8FF60F7F-FFA1-4D55-A264-EC66B430B8A6 Q38004097-06356CA2-D448-4C08-B443-CFFC0C17A051 Q38048856-175DE0EF-DBC9-4FB8-8DCD-4AF5ADD2A2F0 Q38111412-D0C93410-C53A-41C6-91AF-FB1FC80C7D7C Q38843346-4434F4AF-1AD1-4621-A385-C72DE12DF0DB Q41003032-F589ED87-4929-4935-BFB3-4A4E550FB975 Q41871814-48D65792-52B4-4EEC-B612-44F797E966D7 Q43104874-CB8ED520-D354-4481-AA40-0B7EA744D206 Q44867148-59BADA1F-8910-4C80-84F8-CD71486B4B29 Q47932596-73D0AB85-4831-4301-BDF1-8F88D596E614 Q48209073-FC23D243-4A09-4CC7-AF6C-D2BFDACFCE17 Q50079503-8BB78A5F-7AD1-4441-A411-B18A39E3B012 Q56943605-83A81976-0F24-4A67-9110-2C16EE946E5E

P2860

Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.

http://www.wikidata.org/entity/Q33360668

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Ocular inflammation in Behçet ...... and of loss of visual acuity.

@ast

Ocular inflammation in Behçet ...... and of loss of visual acuity.

@en

type

label

Ocular inflammation in Behçet ...... and of loss of visual acuity.

@ast

Ocular inflammation in Behçet ...... and of loss of visual acuity.

@en

prefLabel

Ocular inflammation in Behçet ...... and of loss of visual acuity.

@ast

Ocular inflammation in Behçet ...... and of loss of visual acuity.

@en

P1433

Q33360668-A1C74C9B-05D9-4091-B63A-9C72067D98EE

P1476

Q33360668-D61F8FDC-52BE-42CC-B6B7-393F0CD805B0

P2093

Q33360668-1D4624A4-02D2-4387-B8FD-AE81F98D7F78

Q33360668-1DB9E8AC-E4CF-4D90-B674-AECF08E78C1D

Q33360668-21645C01-FCBE-4BDB-A14C-69C05DA6B5BC

Q33360668-2EA22324-18AE-4CCF-A94F-98FCA6C6A14E

Q33360668-995C9A60-B14E-410B-990D-A230F77DC4B2

Q33360668-B5A202AA-2B75-4A73-8F40-0979DD4FC14F

Q33360668-D234F5BA-B583-4BF8-AA73-4192DCE8481F

Q33360668-F6805CBB-A52B-47A8-B24E-D3D57125A9E0

Q33360668-F8BE08B2-87B4-4E17-A6C0-AF8D302B2146

Q33360668-FA2CA780-9AF3-4FB3-BBF6-BAD6842F0116

P2860

Q33360668-06694B9B-629C-4B78-A883-2BF1483BEC78

Q33360668-13065CF3-06A3-4EBE-B461-130786003D5A

Q33360668-16275A49-BB28-40FA-87FB-9D8E0269EC43

Q33360668-1B84E0C6-9608-4E10-B2D1-55DA54EABBFA

Q33360668-27D3E136-D2F4-49B7-AF05-6F2F28B8C1ED

Q33360668-3C942C6B-ECC5-4008-967E-3A5ABBE514D3

Q33360668-494A5EB6-F601-46C9-A6B0-61ABA879DFB8

Q33360668-4CE2B8B7-B28E-475A-AC7A-F817DC5EC8C5

Q33360668-6152AFEC-51A5-46E7-9DC9-519AAB1D091B

Q33360668-64299F8D-077F-4A89-A471-F240B60C79FA

P304

Q33360668-558E4454-C72E-4D66-BAD9-FB694F6203AB

P31

Q33360668-2FB5FE34-B02F-46E3-A70A-5E23305CD473

P356

Q33360668-33AFBA10-B408-4E20-9CC8-D0F44315460B

P407

Q33360668-F1251B14-D351-4DD0-8BB2-9EF81CAC6B8C

P433

Q33360668-070E1BF8-4509-4B96-BC1E-48B0658FA1FD

P478

Q33360668-FC88E100-2282-4817-AAE3-F14C74F6EAF4

P50

Q33360668-352F1BE4-8B0D-4237-870F-9FC151BCE6F0

Q33360668-A0FCEB1E-C275-416D-AC71-D8661BD57A3F

Q33360668-FBDA769C-479D-422B-9029-D4B0EB564D8B

P577

Q33360668-8A0A97DF-99A4-4FFC-90AE-99486762EBCC

P5875

Q33360668-282EF38A-872D-445E-9F0E-50D1A4CE4F13

P698

Q33360668-A2597E5F-F6A0-4D49-9114-3A8FED8AF17E

P921

Q33360668-62F723D2-B2DD-43A7-85C0-3A5305BFA779

P932

Q33360668-45D684B1-4036-413D-A914-62B024AE5047

P356

J.AJO.2008.06.019

P1433

American Journal of Ophthalmology

P1476

Ocular inflammation in Behçet ...... and of loss of visual acuity.

@en

P2093

C Stephen Foster

http://www.w3.org/2001/XMLSchema#string

Craig Newcomb

http://www.w3.org/2001/XMLSchema#string

Douglas A Jabs

http://www.w3.org/2001/XMLSchema#string

Eric B Suhler

http://www.w3.org/2001/XMLSchema#string

James T Rosenbaum

http://www.w3.org/2001/XMLSchema#string

Jennifer E Thorne

http://www.w3.org/2001/XMLSchema#string

John H Kempen

http://www.w3.org/2001/XMLSchema#string

R Oktay Kaçmaz

http://www.w3.org/2001/XMLSchema#string

Sapna Gangaputra

http://www.w3.org/2001/XMLSchema#string

Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

Behçet's disease: from Hippocrates to the third millennium

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study.

Immunopathology of the noninfectious posterior and intermediate uveitides.

Behçet's disease in Japan and in Great Britain: a comparative study.

Prevalence and clinical aspects of Behcet's disease in the north of Israel.

Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study.

A controlled trial of azathioprine in Behçet's syndrome.

The use of interferon alpha in Behçet disease: review of the literature.

Current concepts in the etiology and treatment of Behçet disease.

P304

828-836

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJO.2008.06.019

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P50

Robert B Nussenblatt

Grace A Levy-Clarke

P577

2008-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23175629

http://www.w3.org/2001/XMLSchema#string

P698

18708181

http://www.w3.org/2001/XMLSchema#string

P921

Behcet's disease

P932

2617769

http://www.w3.org/2001/XMLSchema#string